Kejia Jie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kejia Jie has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Daqing Fan
The department of Head and Neck surgery, Hubei Cancer Hospital, Wuhan, China
1 shared publication - Jian Chen
Department of Oncology, the Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, P.R. China
1 shared publication - Li Zhou
Institute for Vaccine Research at Animal Biosafety Level 3 Laboratory, Wuhan University School of Medicine, Wuhan, China.
1 shared publication - Liang Jiang
Affiliated Hospital of Southwest Medical University, Department of Otolaryngology Head and Neck Surgery, Luzhou City, People's Republic of China
1 shared publication - Qike Jia
The department of Head and Neck surgery, Hubei Cancer Hospital, Wuhan, China
1 shared publication - Wei Li
University of Tennessee Health Science Center
1 shared publication
Latest Publications
- 29 March 2016
- Published by Springer Nature in Tumor Biology
- Vol. 37 (9) , 11753-11762
Interleukin-22 promotes papillary thyroid cancer cell migration and invasion through microRNA-595/Sox17 axis
Interleukin-22 (IL-22) is an inflammatory cytokine mainly produced by activated Th17 and Th22 cells. The data presented here demonstrate that IL-22 induced the migration and invasion of papillary thyroid cancer (PTC) cells. MicroRNA expression analysis and functional studies indicated that IL-22-mediated migration and invasion is positively regulated by miR-595. Further mechanistic studies revealed that sex-determining region Y-box 17 (Sox17) is directly targeted by miR-595. We then demonstrated that IL-22 regulated migration and invasion of PTC cells via inhibiting Sox17 expression. Interestingly, in PTC cell lines and PTC tissues, expression of IL-22 and miR-595 was upregulated and Sox17 downregulated compared with normal thyroid, and their expression levels were closely correlated. Taken together, this present study suggests that IL-22 stimulation enhances the migration and invasion of PTC cells by regulating miR-595 and its target Sox17.
- 29 March 2016
- Published by Springer Nature in Tumor Biology
- Vol. 37 (9) , 11753-11762
Interleukin-22 promotes papillary thyroid cancer cell migration and invasion through microRNA-595/Sox17 axis
Interleukin-22 (IL-22) is an inflammatory cytokine mainly produced by activated Th17 and Th22 cells. The data presented here demonstrate that IL-22 induced the migration and invasion of papillary thyroid cancer (PTC) cells. MicroRNA expression analysis and functional studies indicated that IL-22-mediated migration and invasion is positively regulated by miR-595. Further mechanistic studies revealed that sex-determining region Y-box 17 (Sox17) is directly targeted by miR-595. We then demonstrated that IL-22 regulated migration and invasion of PTC cells via inhibiting Sox17 expression. Interestingly, in PTC cell lines and PTC tissues, expression of IL-22 and miR-595 was upregulated and Sox17 downregulated compared with normal thyroid, and their expression levels were closely correlated. Taken together, this present study suggests that IL-22 stimulation enhances the migration and invasion of PTC cells by regulating miR-595 and its target Sox17.